Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Immediate hypersensitivity reactions to ibuprofen and other arylpropionic acid derivatives

  • Blanca-López, Natalia
  • Pérez-Alzate, D.
  • Doña, Inmaculada
  • Agundez, Javier A.
  • García-Martín, Elena
  • Salas, M.
  • Miranda Alonso, Miguel Ángel
  • Torres, M. J.
  • Cornejo-Garcia, J.A.
  • Blanca, M.
  • Canto, G.
  • Andreu, Inmaculada|||0000-0003-3409-9443
[EN] Background: Although ibuprofen and other arylpropionic acid derivatives (APs) are the most common medicines involved in hypersensitivity drug reactions (HDRs) to NSAIDs, no patient series studies have been performed regarding immediate selective reactions (SRs) to these drugs. Objective: To characterize patients with immediate selective HDRs to ibuprofen and other APs through clinical history and challenge. Methods: Subjects who developed an HDR to APs less than 1 h after drug intake were included. Tolerance to aspirin was assessed and challenge was performed with ibuprofen in all cases, and additionally with the culprit drug (if different) in those patients that tolerated ibuprofen. Serum tryptase levels and tryptase immunohistochemical staining in skin biopsies were also assessed in some patients with a positive DPT to ibuprofen. Results: From a total of 245 patients with a confirmed history of HDRs to APs, 17% were classified as selective immediate hypersensitivity reactors by both clinical history and challenge. A selective response to naproxen and dexketoprofen with tolerance to ibuprofen was found in 16 of 20 cases. Significant differences in serum tryptase levels were observed between 2 and 24 h in the 11 cases that were studied further. Conclusions: Within the group of patients with HDRs to NSAIDs, APs can induce immediate SRs. Within this group, selective responses to a single drug or responders to several APs may exist, suggesting potential immunological crossreactivit, We thank James Perkins for manuscript revision. JA Cornejo-Garciia received funding from the Miguel Servet Program (Ref CP14/00034 (Carlos III National Health Institute, Spanish Ministry of Economy and Competitiveness)). This study was supported by grants from the Carlos III National Health Institute RD12/0013 (RIRAAF Network), FIS PI12/02247 and FIS PI13/02598. It was also supported by the Andalusian Public Health Service (PI-0279-2012 and PI-0463-2013).